Kaili Hu

4.1k total citations
59 papers, 3.1k citations indexed

About

Kaili Hu is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Kaili Hu has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Pharmaceutical Science and 16 papers in Biomaterials. Recurrent topics in Kaili Hu's work include Nanoparticle-Based Drug Delivery (15 papers), Advanced Drug Delivery Systems (13 papers) and RNA Interference and Gene Delivery (9 papers). Kaili Hu is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), Advanced Drug Delivery Systems (13 papers) and RNA Interference and Gene Delivery (9 papers). Kaili Hu collaborates with scholars based in China, United States and Canada. Kaili Hu's co-authors include Xinguo Jiang, Wei Lü, Jianfang Feng, Xiaoling Gao, Qizhi Zhang, Mei Liu, Xiaolu Xu, Zhiqing Pang, Hongbing Wu and Jingwei Li and has published in prestigious journals such as Nature Communications, ACS Nano and Biomaterials.

In The Last Decade

Kaili Hu

59 papers receiving 3.1k citations

Peers

Countries citing papers authored by Kaili Hu

Since Specialization

Citations

This map shows the geographic impact of Kaili Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaili Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaili Hu more than expected).

Fields of papers citing papers by Kaili Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaili Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaili Hu. The network helps show where Kaili Hu may publish in the future.

Co-authorship network of co-authors of Kaili Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaili Hu. A scholar is included among the top collaborators of Kaili Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaili Hu. Kaili Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis 2025 ·Acta Pharmaceutica Sinica B ·(unknown), Peng Xian, (unknown), (unknown), (unknown), (unknown), Kaili Hu	11
2	Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer 2025 ·Biomaterials ·Xian Peng, (unknown), (unknown), (unknown), Yanjie Song, (unknown), (unknown), Huizhen Liu, Donald P. Green, (unknown), Kaili Hu	1
3	Research on the collaborative mechanism between site selection optimization model and control of green space planning under the background of urban renewal 2025 ·Discover Sustainability ·Xiangyun Li, Donghua Dai, Jingwen Dong, Kaili Hu	1
4	Study on the preparation of stabilizer-free silymarin nanocrystals and its oral absorption mechanisms 2024 ·International Journal of Pharmaceutics X ·Liangxing Tu, Ping Han, Yongbing Sun, (unknown), Kaili Hu, Meng Cheng, (unknown), Jianfang Feng, (unknown)	2
5	Biomimetic “nano-spears” for CAFs-targeting: splintered three “shields” with enhanced cisplatin anti-TNBC efficiency 2024 ·Journal of Controlled Release ·(unknown), (unknown), (unknown), Kaili Hu	9
6	Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide 2024 ·Bioconjugate Chemistry ·(unknown), (unknown), (unknown), (unknown), Wenhao Zhu, Wen Zhao, Hongzhi Xu, Kaili Hu	5
7	The emerging role of microglia in the development and therapy of multiple sclerosis 2024 ·International Immunopharmacology ·(unknown), (unknown), Mei Liu, Kaili Hu	4
8	Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma 2024 ·Biomaterials ·(unknown), (unknown), Kaili Hu	13
9	HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma 2024 ·Cancer Nanotechnology ·(unknown), (unknown), (unknown), (unknown), Lei Zhang, Yanlong Hong, Kaili Hu	3
10	Puerperium experience and lifestyle in women with gestational diabetes mellitus and overweight/obesity in China: A qualitative study 2023 ·Frontiers in Psychology ·Jing He, Kaili Hu, Xing Cui, (unknown), Tieying Zeng, Hui Wang	5
11	Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment 2023 ·Advanced Science ·Jiaxin Zhang, Leaf Huang, Guangbo Ge, Kaili Hu	32
12	Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapy 2023 ·International Journal of Pharmaceutics ·Xiao Guang Zhao, (unknown), Jing Wang, Xiaolu Xu, (unknown), Mei Liu, Kaili Hu	19
13	Intranasal delivery of Borneol/R8dGR peptide modified PLGA nanoparticles co-loaded with curcumin and cisplatin alleviate hypoxia in pediatric brainstem glioma which improves the synergistic therapy 2023 ·Journal of Controlled Release ·Xiao Guang Zhao, (unknown), (unknown), Kaili Hu	21
14	The Role of CD4+ T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines 2022 ·Journal of Neuroimmune Pharmacology ·Jing Wang, (unknown), Mei Liu, Kaili Hu	7
15	Experimental murine models of brainstem gliomas 2021 ·Drug Discovery Today ·(unknown), (unknown), Kaili Hu	3
16	Natural products remodel cancer-associated fibroblasts in desmoplastic tumors 2020 ·Acta Pharmaceutica Sinica B ·(unknown), Leaf Huang, Kaili Hu	39
17	Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat 2013 ·International Journal of Pharmaceutics ·Liangxing Tu, Yueneng Yi, Wei Wu, Fuqiang Hu, Kaili Hu, Jianfang Feng	36
18	Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease 2011 ·International Journal of Pharmaceutics ·Kaili Hu, Yanbin Shi, Wenming Jiang, Jiaying Han, Shixian Huang, Xinguo Jiang	201
19	Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer 2008 ·Biochemical and Biophysical Research Communications ·Jun Chen, Xiaoling Gao, Kaili Hu, Zhiqing Pang, Jia Cai, Jingwei Li, Hongbing Wu, Xinguo Jiang	33
20	Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery 2005 ·Journal of Controlled Release ·Wei Lü, Yan Zhang, Yu‐zhen Tan, Kaili Hu, Xinguo Jiang, Shoukuan Fu	250

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact